Scott Cullison Email & Phone Number
@targacept.com
4 phones found area 832 and 336
LinkedIn matched
Who is Scott Cullison? Overview
A concise factual answer block for searchers comparing this professional profile.
Scott Cullison is listed as Consultant and Owner at Stride BDCom Consulting LLC, based in United States, United States, United States. AeroLeads shows a work email signal at targacept.com, phone signal with area code 832, 336, and a matched LinkedIn profile for Scott Cullison.
Scott Cullison previously worked as Consultant/Owner at Stride Bdcom Consulting Llc and VP Business Development and Commercial Planning at Peloton Therapeutics. Scott Cullison holds Mba from Wake Forest University School Of Business.
Email format at Stride BDCom Consulting LLC
This section adds company-level context without repeating Scott Cullison's masked contact details.
AeroLeads found 2 current-domain work email signals for Scott Cullison. Compare company email patterns before reaching out.
About Scott Cullison
Driven, results-oriented individual with over 20 years of experience in the pharmaceutical industry and a broad range of expertise across business development, alliance management, commercialization, product management, R&D program team leadership, and strategic planning. Secured multiple transformative deals with major pharmaceutical companies that validated company’s scientific platform, provided non-dilutive capital, increased capabilities, and fueled meaningful growth and value creation. Executed robust M&A strategic process to merge company providing meaningful exit to investors and stakeholders. Management of commercial product experience and lead pre-commercial market research and market access planning and competitive intelligence initiatives. Commercial experience across large primary care and specialty orphan indications with both small molecules and personalized cell therapies. Proven leadership skills within business development, commercialization, alliance management, execution of internal R&D program operations and strategic planning brings impactful executive to organization. Elected to exit last position following completion of $2.2 billion acquisition of Peloton Therapeutics by Merck and formed my own consulting company. Seeking new clients to assist with business development and/or commercial planning.
Listed skills include Pharmaceutical Industry, Biotechnology, Drug Development, Clinical Development, and 11 others.
Scott Cullison's current company
Company context helps verify the profile and gives searchers a useful next step.
Scott Cullison work experience
A career timeline built from the work history available for this profile.
Consultant/Owner
Stride BDCom Consulting, LLC provides professional executive level business development (BD) and/or commercial planning (CP) strategic/tactical services in the biotech/pharma industry. BD Services are from pitch deck refinement and outreach, facilitating due diligence, through negotiation of term sheets/agreements, and even alliance management. CP Services.
Vp Business Development And Commercial Planning
Executed definitive agreement for Peloton to be acquired by Merck for $2.2 billion. Leadership of business development and commercial planning strategy and execution for portfolio of late-stage and preclinical oncology programs and a preclinical non-oncology asset. Effectively identify, develop and negotiate potential licensing or strategic deal.
Svp Business Development (Consultant)
Leadership of all business development strategy and tactical execution to explore partnership opportunities for clinical stage programs in ophthalmology and diabetic related complications (nephropathy, neuropathy, etc). Departed after company reorganized following Phase 2 clinical failure of lead program.
Vice President, Commercial Planning And Program Management
Leadership of all global commercial planning activities and pre-launch strategic initiatives for late-stage gene modified T cell therapy product adjunctive to allogeneic hematopoietic stem cell transplant (HSCT) for orphan inherited blood disorders and malignant diseases. Responsible for aligning cross functional program research and development.
Vice President, Business Development
Leadership of all business development activities related to identifying, developing and negotiating potential out-licensing, in-licensing and strategic deal opportunities. Reported directly to CEO and a member of Executive Committee. Executed a robust strategic process to identify, evaluate and negotiate potential strategic opportunities for company..
Senior Director, Business & Commercial Development; Therapeutic Area Leader - Mood Disorders
Identified, developed, and negotiated potential R&D and commercial strategic collaborations. After securing collaboration with AstraZeneca for a compound in development for major depressive disorder in December 2009, served as the Development Liaison and Alliance Manager to lead compound in all aspects of development and pre-launch commercial activities..
Director, Business & Commercial Development
Identified, developed, and negotiated potential R&D and commercial strategic collaborations. In second half 2009, ran a competitive auction process for a Phase 3 ready compound for depression with most major pharmaceutical companies. Co-ordinated due diligence and term sheet proposals then negotiated contracts in parallel with multiple selected companies..
Senior Manager, Licensing & Commercialization
Identified, developed, and negotiated potential R&D and commercial strategic collaborations. Completed major, company transforming deal with AstraZeneca for cognitive disorders and schizophrenia. Contract included a license for lead molecule in Phase 2, a robust 4-year research collaboration, an option agreement related to other targets, a right of first.
Business Development Analyst
Identified, developed, and negotiated potential R&D and commercial strategic collaborations. Co-lead in overseeing due diligence, financial analysis, and contract negotiation in acquisition of a marketed product, Inversine. Managed transition of all assets related to the acquisition, product re-launch, and continued to oversee all product related.
Scott Cullison education
Mba
Bachelor Of Science (Bs), Molecular And Cellular Biology
Frequently asked questions about Scott Cullison
Quick answers generated from the profile data available on this page.
What company does Scott Cullison work for?
Scott Cullison works for Stride BDCom Consulting LLC.
What is Scott Cullison's role at Stride BDCom Consulting LLC?
Scott Cullison is listed as Consultant and Owner at Stride BDCom Consulting LLC.
What is Scott Cullison's email address?
AeroLeads has found 2 work email signals at @targacept.com for Scott Cullison at Stride BDCom Consulting LLC.
What is Scott Cullison's phone number?
AeroLeads has found 4 phone signal(s) with area code 832, 336 for Scott Cullison at Stride BDCom Consulting LLC.
Where is Scott Cullison based?
Scott Cullison is based in United States, United States, United States while working with Stride BDCom Consulting LLC.
What companies has Scott Cullison worked for?
Scott Cullison has worked for Stride Bdcom Consulting Llc, Peloton Therapeutics, Aerpio Pharmaceuticals, Bellicum Pharmaceuticals, Inc., and Targacept, Inc..
How can I contact Scott Cullison?
You can use AeroLeads to view verified contact signals for Scott Cullison at Stride BDCom Consulting LLC, including work email, phone, and LinkedIn data when available.
What schools did Scott Cullison attend?
Scott Cullison holds Mba from Wake Forest University School Of Business.
What skills is Scott Cullison known for?
Scott Cullison is listed with skills including Pharmaceutical Industry, Biotechnology, Drug Development, Clinical Development, Business Development, Lifesciences, Technology Transfer, and Drug Discovery.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial